A Safety and Efficacy of Supralimus™ Core™ Sirolimus Eluting Stent at MAX DDHV Institute

NACompletedINTERVENTIONAL

Enrollment

105

Participants

Timeline

Start Date

July 31, 2006

Primary Completion Date

July 31, 2007

Study Completion Date

March 31, 2008

Conditions

Coronary Artery Disease

Interventions

DEVICE

Supralimus-Core™

Sirolimus Eluting Cobalt Chromium based coronary stent system

DEVICE

Supralimus™ Core™ Sirolimus eluting stent

Supralimus™ Core™ Sirolimus eluting stent intended to treat coronary artery disease.

Trial Locations (1)

Max Heart and Vascular Institute, New Delhi

All Listed Sponsors

lead

Sahajanand Medical Technologies Limited

INDUSTRY

NCT00811616 - A Safety and Efficacy of Supralimus™ Core™ Sirolimus Eluting Stent at MAX DDHV Institute | Biotech Hunter | Biotech Hunter